Clinical Cell Culture renames
Tuesday, 10 June, 2008
Clinical Cell Culture (ASX: CCE) is to be re-named Avita Medical following a shareholder meeting.
The resolution to change the company's name was passed by the vast majority of shareholders.
Shareholders have also resolved to consolidate the company's shares on a 10:1 basis.
The company believes that a name change and the recent shake-up of the boardroom will help drive sales of the company's products, such as the ReCell autologous skin cell kit, further.
SEQ koala population carries immunity to retrovirus
Koalas from a population north of the Brisbane River appear to have evolved a unique genomic...
RSV immunisation program for babies slashes hospital stays
An Australian-first study has demonstrated the effectiveness of immunisation against respiratory...
A targeted treatment option for psoriasis
New research from MedUni Vienna paves the way for the development of a therapy that not only...